Genezen

Produces viral vectors for cell and gene therapy programs.

genezen.comBiotechnology, Pharmaceuticals217 employeesUS
PrivateFounded 2014Private Equity (2023)Viral vector manufacturingProcess developmentCell transduction servicesAnalytical testing servicesGMP production
Showing 15 matching jobs
Title
Process Engineer I
Full Time · $65K-$85K · 0+ YOE
Lexington or Fishers · Onsite
Associate, Quality Operations
Full Time · 3+ YOE
Fishers or Indianapolis or Lexington · Onsite
Director of Business Development
Full Time · $165K-$185K · 5+ YOE
Lexington or Fishers · Onsite
Stability Manager, Quality Control
Full Time · $130K-$150K · 8+ YOE
Lexington or Fishers · Onsite
QC Analyst - Bioassay Temp - 2nd Shift (1-9:30pm)
Temporary · 2+ YOE
Lexington, Massachusetts, United States · Onsite
Automation Engineer I/II/III
Full Time · $65K-$130K · 2+ YOE
Lexington, Massachusetts, United States · Onsite
Manufacturing Supervisor - 1st Shift
Full Time · 5+ YOE
Lexington or Fishers · Onsite
Manufacturing Technician I/II/III (2nd Shift)
Full Time · 2+ YOE
Lexington, Massachusetts, United States · Onsite
Manufacturing Supervisor - 2nd Shift (2:00-10:30pm)
Full Time · 3+ YOE
Lexington, Massachusetts, United States · Onsite
Validation Engineer II/III (CSV)
Full Time · $90K-$130K · 5+ YOE
Lexington or Fishers · Onsite
Lead, QCTS Data Integrity & Computerized Systems
Full Time · $110K-$150K · 10+ YOE
Lexington or Fishers · Onsite
Sr/Principal Scientist - Upstream Process Development
Full Time · $120K-$170K · 8+ YOE
Lexington, Massachusetts, United States · Onsite
Validation Technician I/II
Full Time · $56K-$79K/yr · 1+ YOE
Lexington or Fishers · Onsite
Specialist I/II/III, Calibration
Full Time · 3+ YOE
Fishers or Lexington · Onsite
Sr. Program Manager
Full Time · 5+ YOE
Lexington or Fishers · Onsite

About Genezen

Activities
Viral vector manufacturingProcess developmentCell transduction servicesAnalytical testing servicesGMP production
HeadquartersUS
Industries
BiotechnologyPharmaceuticals
NameGenezen
Employees217
TypePrivate
TaglineProduces viral vectors for cell and gene therapy programs.
Founded2,014
Websitegenezen.com
Latest Funding RoundPrivate Equity
Latest Funding Year2,023
Latest Funding Amount18,500,000
Latest Investors
Ampersand Capital Partners